These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32084302)

  • 1. Glucose transporter 1 in rheumatoid arthritis and autoimmunity.
    Zezina E; Sercan-Alp O; Herrmann M; Biesemann N
    Wiley Interdiscip Rev Syst Biol Med; 2020 Jul; 12(4):e1483. PubMed ID: 32084302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes.
    Garcia-Carbonell R; Divakaruni AS; Lodi A; Vicente-Suarez I; Saha A; Cheroutre H; Boss GR; Tiziani S; Murphy AN; Guma M
    Arthritis Rheumatol; 2016 Jul; 68(7):1614-26. PubMed ID: 26815411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.
    Qiu J; Wu B; Goodman SB; Berry GJ; Goronzy JJ; Weyand CM
    Front Immunol; 2021; 12():652771. PubMed ID: 33868292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis.
    Petrasca A; Phelan JJ; Ansboro S; Veale DJ; Fearon U; Fletcher JM
    Rheumatology (Oxford); 2020 Oct; 59(10):2816-2828. PubMed ID: 32047926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycolysis, a driving force of rheumatoid arthritis.
    Gan PR; Wu H; Zhu YL; Shu Y; Wei Y
    Int Immunopharmacol; 2024 May; 132():111913. PubMed ID: 38603855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
    Caro-Maldonado A; Wang R; Nichols AG; Kuraoka M; Milasta S; Sun LD; Gavin AL; Abel ED; Kelsoe G; Green DR; Rathmell JC
    J Immunol; 2014 Apr; 192(8):3626-36. PubMed ID: 24616478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Increased Lactate Dehydrogenase A Activity and Aerobic Glycolysis on the Proinflammatory Profile of Autoimmune CD8+ T Cells in Rheumatoid Arthritis.
    Souto-Carneiro MM; Klika KD; Abreu MT; Meyer AP; Saffrich R; Sandhoff R; Jennemann R; Kraus FV; Tykocinski L; Eckstein V; Carvalho L; Kriegsmann M; Giese T; Lorenz HM; Carvalho RA
    Arthritis Rheumatol; 2020 Dec; 72(12):2050-2064. PubMed ID: 32602217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: Latest evidence and therapeutic approaches in rheumatoid arthritis.
    Masoumi M; Mehrabzadeh M; Mahmoudzehi S; Mousavi MJ; Jamalzehi S; Sahebkar A; Karami J
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107064. PubMed ID: 33039953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis.
    Cai WW; Yu Y; Zong SY; Wei F
    Inflamm Res; 2020 Nov; 69(11):1087-1101. PubMed ID: 32797249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A.
    Koedderitzsch K; Zezina E; Li L; Herrmann M; Biesemann N
    Sci Rep; 2021 Sep; 11(1):19385. PubMed ID: 34588517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis.
    Bustamante MF; Garcia-Carbonell R; Whisenant KD; Guma M
    Arthritis Res Ther; 2017 May; 19(1):110. PubMed ID: 28569176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Targeting of GLUT1 to Control Autoreactive T Cell Responses.
    Di Dedda C; Vignali D; Piemonti L; Monti P
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the effect of the GLUT-1 inhibitor BAY-876 on T cells and macrophages.
    Chen Z; Vaeth M; Eckstein M; Delgobo M; Ramos G; Frantz S; Hofmann U; Gladow N
    Eur J Pharmacol; 2023 Apr; 945():175552. PubMed ID: 36739076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYLD suppression enhances the pro-inflammatory effects and hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes by enhancing NF-κB activation.
    Zhang LM; Zhou JJ; Luo CL
    Arthritis Res Ther; 2018 Oct; 20(1):219. PubMed ID: 30285829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis.
    Zafari P; Rafiei A; Esmaeili SA; Moonesi M; Taghadosi M
    J Cell Physiol; 2019 Dec; 234(12):21575-21587. PubMed ID: 31062383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.
    Koga T; Sato T; Furukawa K; Morimoto S; Endo Y; Umeda M; Sumiyoshi R; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Origuchi T; Nakamura H; Kawakami A
    Arthritis Rheumatol; 2019 May; 71(5):766-772. PubMed ID: 30462889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.
    Wang C; Xiao Y; Lao M; Wang J; Xu S; Li R; Xu X; Kuang Y; Shi M; Zou Y; Wang Q; Liang L; Zheng SG; Xu H
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32938830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes.
    Yoshitomi H
    Front Immunol; 2019; 10():1395. PubMed ID: 31275325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast-Like Synoviocytes Glucose Metabolism as a Therapeutic Target in Rheumatoid Arthritis.
    de Oliveira PG; Farinon M; Sanchez-Lopez E; Miyamoto S; Guma M
    Front Immunol; 2019; 10():1743. PubMed ID: 31428089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid
    Freemerman AJ; Zhao L; Pingili AK; Teng B; Cozzo AJ; Fuller AM; Johnson AR; Milner JJ; Lim MF; Galanko JA; Beck MA; Bear JE; Rotty JD; Bezavada L; Smallwood HS; Puchowicz MA; Liu J; Locasale JW; Lee DP; Bennett BJ; Abel ED; Rathmell JC; Makowski L
    J Immunol; 2019 Feb; 202(4):1265-1286. PubMed ID: 30659108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.